Valantine Hannah

CIK: 0001855608
Director

Valantine Hannah is a corporate insider at BridgeBio Pharma, Inc. (BBIO) filing SEC Form 4 transactions. 75 transactions across 3 companies, totaling $124,554 in purchases and $3,098,264 in sales. Source: SEC EDGAR.

Total Transactions
75
Total Buy Value
$125K
Total Sell Value
$3.10M
Net Activity
$-2.97M
Last Transaction
Jul 2026
Companies
3

Companies

Transaction History

Source: SEC EDGAR Form 4 insider transaction filings.

Type
Exercise
Shares
5,125
Price
$7.96
Value
$41K
Type
Exercise
Shares
16,048
Price
$14.19
Value
$228K
Type
Exercise
Shares
7,606
Price
$20.56
Value
$156K
Type
Sale
Shares
100
Price
$36.55
Value
$4K
Type
Sale
Shares
28,679
Price
$36.14
Value
$1.04M
Type
Exercise
Shares
5,125
Price
$7.96
Value
$41K
Type
Exercise
Shares
16,048
Price
$14.19
Value
$228K
Type
Exercise
Shares
7,606
Price
$20.56
Value
$156K
Type
Sale
Shares
2,196
Price
$68.57
Value
$151K
Type
Exercise
Shares
2,808
Price
$41.73
Value
$117K
Type
Award
Shares
5,277
Price
$68.92
Value
$364K
Type
Sale
Shares
2,808
Price
$68.00
Value
$191K
Type
Exercise
Shares
2,808
Price
$41.73
Value
$117K
Type
Award
Shares
3,990
Price
-
Value
-
Type
Sale
Shares
12,103
Price
$23.11
Value
$280K
Type
Award
Shares
9,795
Price
-
Value
-
Type
Award
Shares
223,492
Price
$1.58
Value
$353K
Type
Exercise
Shares
25,484
Price
-
Value
-
Type
Sale
Shares
25,484
Price
$66.07
Value
$1.68M
Type
Exercise
Shares
25,484
Price
$48.45
Value
$1.23M